Real-time fluorescent quantitative PCR assay for measuring cytomegalovirus DNA load in patients after haematopoietic stem cell transplantation

Chinese Medical Journal

Volumn 119, Issue 10, 2006, Pages 871-874

  Fan, Jun ^a   Ma, Wei Hang ^a   Yang, Mei Fang ^a   Xue, Han ^a   Gao, Hai Nü ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cytomegalovirus; Haematopoietic stem cell transplantation; Polymerase chain reaction; Real time systems

Indexed keywords

VIRUS ANTIGEN; VIRUS DNA;

ADOLESCENT; ADULT; ANTIGEN EXPRESSION; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MONITORING; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REINFECTION; STATISTICAL ANALYSIS; VIRUS LOAD;

EID: 33744465527     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200605020-00014     Document Type: Article

References (11)

1. Wei GQ, Lin MF, Huang H, Cai Z. Human cytomegalovirus protects multiple myeloma cell line KM3 cells from apoptosis induced by growth factor withdrawal. Chin Med J 2004; 117:903-907.
2. Cortez KJ, Fischer SH, Fahle GA, Calhoun LB, Childs RW, Barrett AJ, et al. Clinical trial of quantitative real-time polymerase chain reaction for detection of CMV in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients. J Infect Dis 2003; 188:967-972.
3. Boeckh M, Boivin G. Quantitation of cytomegalovirus: methodological aspects and clinical applications. Clin Microbiol Rev 1998; 11:533-554.
4. Meyer-Koenig U, Weidmann M, Kirste G, Hufert FT. Cytomegalovirus infection in organ-transplant recipients: diagnostic value of pp65 antigen test, qualitative polymerase chain reaction (PCR) and quantitative Taqman PCR. Transplantation 2004; 77:1692-1698.
5. Fries BC, Riddell SR, Kim HW, Corey L, Dahlgren C, Woolfrey A, et al. Cytomegalovirus disease before hematopoietic cell transplantation as a risk for complications after transplantation. Biol Blood Marrow Transplant 2005; 11:136-148.
6. Caliendo AM, St George K, Kao SY, Allega J, Tan BH, LaFontaine R, et al. Comparison of quantitative cytomegalovirus (CMV) PCR in plasma and CMV antigenemia assay: clinical utility of the prototype amplicor CMV monitor test in transplant recipients. J Clin Microbiol 2000; 38:2122-2127.
7. Gerna G, Sarasini A, Lilleri D, Percivalle E, Torsellini M, Baldanti F, et al. In vitro model for the study of the dissociation of increasing antigenemia and decreasing DNAemia and viremia during treatment of human cytornegalovirus infection with ganciclovir in transplant recipients. J Infect Dis 2003; 188:1639-1647.
8. Nitsche A, Steuer N, Schmidt CA, Landt O, Ellerbrok H, Pauli G. et al. Detection of human cytomegalovirus DNA by real-time quantitative PCR. J Clin Microbiol 2000; 38: 2734-2737.
9. Martin-Davila P, Fortun J, Gutierrez C, Marti-Belda P, Candelas A, Honrubia A, et al. Analysis of a quantitative PCIR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J Clin Virol 2005; 33:138-144.
10. Wheat RL, Clark PY, Brown MG. Quantitative measurement of infectious murine cytomegalovirus genomes in real-time PCR. J Virol Methods 2003; 112: 107-113.
11. Kalpoe JS, Kroes AC, de Jong MD, Schinkell J, de Brouwer CS, Beersma MF, et al. Validation of clinical application of cytomegalovirus plasma DNA load measurement and definition of treatment criteria by analysis of correlation to antigen detection. J Clin Microbiol 2004; 42:1498-1504.